omniture
HYUNDAI BIOSCIENCE

Latest News

Breakthrough in Long COVID: An investigator-initiated trial (IIT) with Hyundai Bioscience's Xafty by UCSD

SAN DIEGO, Sept. 17, 2024 /PRNewswire/ -- Hyundai Bioscience USA announced that it has signed an MO...

2024-09-18 09:26 1262

Hyundai Bioscience announces XAFTY®, a groundbreaking broad-spectrum antiviral capable of treating COVID-19, mpox, and dengue

* Hyundai Bioscience presents development updates of its broad-spectrum antiviral at the "Disease...

2024-09-11 14:25 1119

Hyundai Bioscience to conduct phase 3 clinical trial for high-risk group of COVID-19 patients with the goal of emergency use authorization

* "Xafty® can be the only oral COVID-19 treatment that can be prescribed to high-risk group patie...

2024-08-28 17:29 1190

ADM Korea Announces Niclosamide-based Metabolic Anticancer Drug's First Clinical Trial Target as 'Prostate Cancer Patients Resistant to Hormone Therapy'

* IND for clinical study for combination therapy with hormone therapy in prostate cancer patients...

2024-07-11 14:07 1947

Hyundai Bioscience succeeds in developing 'Multi-treatment for mosquito-borne viral infections' including Dengue Fever

* Developed a 'Niclosamide-based multi-treatment drug' that can simultaneously treat mosquito-bor...

2024-06-26 09:17 1682

Hyundai Bioscience's antiviral for Dengue Fever to enter clinical trials in Brazil

* "Aiming to offer a Dengue antiviral treatment course in $100 price range" * Hyundai Bioscience...

2024-04-25 21:41 1498

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

* The only solution for intractable cancer caused by mutations in the p53 gene * Planning clinica...

2024-04-25 17:11 1354

Hyundai Bioscience announces its successful result from a preclinical study of a Niclosamide-based oral anticancer drug to treat triple-negative breast cancer

* Clinical trials of Niclosamide-based oral metabolic anticancer drug to commence for patients wi...

2024-04-22 17:51 1375

Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization

SEOUL, South Korea, April 19, 2024 /PRNewswire/ -- South Korea's biotechnology company Hyundai Bios...

2024-04-19 13:17 2237

Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization

SEOUL, South Korea, April 18, 2024 /PRNewswire/ -- South Korea's biotechnology company Hyundai Bio...

2024-04-19 10:54 2270

A 'Game Changer' COVID-19 drug from Korea was introduced in a world class academic journal

SEOUL South Korea, May 23, 2021 /PRNewswire/ -- Hyundai Bioscience (KOSDAQ 048410) announced on the...

2021-05-24 08:16 1794

An oral antiviral drug from Korea may be a problem solver for COVID-19

SEOUL, South Korea, May 13, 2021 /PRNewswire/ -- Hyundai Bioscience (KOSDAQ 048410) announced that ...

2021-05-13 16:37 1748

CNPharm has succeeded in maintaining IC100 for 24 hours with one injection

- Trail-blazing diversification of the repurposing of Niclosamide - Full-scale clinical preparation ...

2021-04-19 20:15 1603

Hyundai Bioscience leads in the repurposing of Niclosamide

SEOUL, South Korea, April 8, 2021 /PRNewswire/ -- A research paper by a South Korean bio tech compa...

2021-04-08 17:17 1925

Hyundai Bioscience Develops Injection Drug for Potential Treatment of Severe Cases of COVID-19

SEOUL, South Korea, Dec. 22, 2020 /PRNewswire/ -- Hyundai Bioscience (KOSDAQ symbol: 048410) announ...

2020-12-23 10:09 1674

Hyundai Bioscience announced that its COVID-19 oral drug solved Niclosamide's inhibitory concentration problem

SEOUL, South Korea, Dec. 8, 2020 /PRNewswire/ -- Hyundai Bioscience (KOSDAQ symbol: 048410) release...

2020-12-08 21:00 1309

Hyundai Bioscience: A Korean bio-tech solves the bioavailability issue of Niclosamide

SEOUL, South Korea, Oct. 29, 2020 /PRNewswire/ -- Expectations are increasing as a Korean bio-tech ...

2020-10-29 20:00 7358

'Curing Cancer without Surgery'

* "Successful disappearance of tumors in subjects upon administering the pain-free anticancer dru...

2020-06-30 15:10 1492